Contraception
Volume 71, Issue 3 , Pages 183-187 , March 2005

Comparison of the metabolic effects of oral contraceptive and nonhormonal contraceptive use in women over 40 years old

  • Sawittri Suwikrom

      Affiliations

    • Department of Obstetrics and Gynecology, Faculty of Medicine, Thammasat University, Pathumthani, 12121, Thailand
    • Corresponding Author InformationCorresponding author. 33/209 Soi Chokchai 4 Ladpraw Road, Ladpraw, Bangkok, 10230 Thailand. Tel.: +66 1 933 8455; fax: +66 2 514 0435.
    • ,
  • Unnop Jaisamrarn

      Affiliations

    • Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand

Received 17 March 2004 ,Revised 23 September 2004 ,Accepted 4 October 2004.

References 

  1. Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. In: 6th ed.. Philadelphia: Lippincott Williams & Wilkins; 1999;p. 643–724
  2. Taechakraichana N, Limpaphayom K. Changes in the menopause. In:  Taechakraichana N editors. Hormone replacement therapy in the menopause. Bangkok: Beyond Enterprise; 2000;p. 1–32
  3. Cerel-Suhl SL, Yeager BF. Update on oral contraceptive pills. Am. Fam. Phys. 1999;60:2073–2084
  4. Weisberg E, Fraser IS. Perimenopausal menstrual disturbances, fertility and the need for contraception. In:  Wren BG,  Nachtrgall LE editor. Clinical management of the menopause. 1st ed.. Sydney: McGraw-Hill Book Company; 1996;p. 16–31
  5. Stenchever MA. Risks of oral contraceptive use in women over 35. J. Reprod. Med. 1993;38:1030–1035
  6. Shaaban MM. The perimenopause and contraception. Maturitas. 1996;23:181–192
  7. Suwikrom S, Jaisamrarn U, Thaneepanichsakul S. A comparison of oral contraceptive and non-hormonal contraceptive use in women over 40. Thai J. Obstet. Gynaecol. 2002;14:285–290
  8. WHO. Improving access to quality case in family planning. Medical eligibility criteria for contraceptive use methods. Geneva: World Health Organizaton; 1996;
  9. Reinprayoon D. Oral contraceptive pills. In:  Thaneepanichsakul S,  Reinprayoon D,  Niruttisart S,  Jaisamrarn U editor. Family planning and contraceptive technology. Bangkok: Desire Publishing; 2000;p. 69–106
  10. Jean JL, Karen MR. Clinical laboratory science: the basics and routine techniques. In: 4th ed.. Missouri: Mosby Inc.; 1999;p. 229–278
  11. Stanley SR. Lynch's medical laboratory technology. In: 4th ed.. Tokyo: WB Saunders Company; 1983;p. 119–150
  12. Loke DF, Ng CS, Holck S, Hall PE, Ratnam SS. Lipid and biochemical changes after low-dose oral contraception. Contraception. 1992;46:227–241
  13. Ahren T, Victor A, Lithell H, Johansson ED. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring: I. Carbohydrate metabolism and liver function. Contraception. 1981;24:415–427
  14. Ho PC, Liu WT, Kwan MS. Serum lipids in Chinese patients using oral contraceptive pills. Contraception. 1990;41:55–61
  15. Van der Vange N, Kloosterboer HJ, Haspels AA. Effects of seven low-dose combined oral contraceptives on high density lipoprotein subfractions. Br. J. Obstet. Gynaecol. 1987;94:559–567
  16. Roy S, Mishell DR, Gray G, et al. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Am. J. Obstet. Gynecol. 1980;136:920–931

PII: S0010-7824(04)00271-9

doi: 10.1016/j.contraception.2004.10.002

Contraception
Volume 71, Issue 3 , Pages 183-187 , March 2005

Article Tools

* Image Usage & Resolution